Shame on you Merck

Merck continues it's stellar string of "achievements" by creating a fraudulent peer-review journal to publish data that casts a favorable light on Fosamax and other drugs. I'm not surprised at this course off action from Merck, a company that hasn't had a blockbuster drug in years. I am more furious at Elsevier, a respected academic journal publisher, that did NOT [...]